Ypsomed Holding AG (XSWX:YPSN) FCF Margin %: -0.08% (As of Mar. 2026)

What is Ypsomed Holding AG FCF Margin %?

Ypsomed Holding AG XSWX:YPSN +1.91% 91 FCF Margin % is -0.08% as of Mar. 2026. GuruFocus rates XSWX:YPSN with a GF Score™ of 91/100 and a GF Value™ of CHF397.52 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Ypsomed Holding AG ranks worse than 55.09% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ypsomed Holding AG's Free Cash Flow for the six months ended in Mar. 2026 was CHF-0.3 Mil. Ypsomed Holding AG's Revenue for the six months ended in Mar. 2026 was CHF368.3 Mil. Therefore, Ypsomed Holding AG's FCF Margin % for the quarter that ended in Mar. 2026 was -0.08%.

As of today, Ypsomed Holding AG's current FCF Yield % is -0.35%.

The historical rank and industry rank for Ypsomed Holding AG's FCF Margin % or its related term are showing as below:

XSWX:YPSN' s FCF Margin % Range Over the Past 10 Years
Min: -17.66 Med: -8.48 Max: 9.47
Current: -2.24

During the past 13 years, the highest FCF Margin % of Ypsomed Holding AG was 9.47%. The lowest was -17.66%. And the median was -8.48%.

XSWX:YPSN's FCF Margin % is ranked worse than
55.09% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.1 vs XSWX:YPSN: -2.24

Ypsomed Holding AG FCF Margin % Related Terms

Ypsomed Holding AG FCF Margin % Historical Data

* Premium members only.

The historical data trend for Ypsomed Holding AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ypsomed Holding AG FCF Margin % Chart

Ypsomed Holding AG Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

FCF Margin %

Get a 7-Day Free Trial

-8.98

-7.97

-5.85

-17.22

-2.24

Ypsomed Holding AG Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25	Sep25	Mar26
FCF Margin %	Get a 7-Day Free Trial															-5.31	-21.93	-13.63	-4.42	-0.08

XSWX:YPSN vs ISRG, BDX, MDLN: FCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ypsomed Holding AG FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's FCF Margin % falls into.

Save Embed

91GF Score

Ypsomed Holding AG XSWX:YPSN

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Ypsomed Holding AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Ypsomed Holding AG's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2026 )	/	Revenue (A: Mar. 2026 )
	=	-16.344	/	730.982
	=	-2.24 %

Ypsomed Holding AG's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-0.31100000000001	/	368.294
	=	-0.08 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -0.08% mean?

Ypsomed Holding AG (XSWX:YPSN) has a FCF Margin % of -0.08% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ypsomed Holding AG and its competitors. According to the industry distribution chart, Ypsomed Holding AG ranks #449 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 55.1%.

Is Ypsomed Holding AG's FCF Margin % too high?

Ypsomed Holding AG's current FCF Margin % is -0.08%. Based on the distribution chart, Ypsomed Holding AG ranks #449 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Ypsomed Holding AG has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Ypsomed Holding AG's FCF Margin % compare to ISRG and BDX?

According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #449 out of 815 companies for FCF Margin %. This places Ypsomed Holding AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Medical Devices & Instruments company?

A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ypsomed Holding AG and its competitors. Ypsomed Holding AG's current FCF Margin % is -0.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Ypsomed Holding AG stock overvalued right now?

Based on GuruFocus' analysis, Ypsomed Holding AG (XSWX:YPSN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF397.52, compared to a current price of CHF353.00 — trading 11.2% below its estimated fair value. The current FCF Margin % is -0.08%. Ypsomed Holding AG's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Ypsomed Holding AG (XSWX:YPSN), the current FCF Margin % is -0.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of CHF353.00 is trading 11.2% below its estimated GF Value™ of CHF397.52. GuruFocus considers Ypsomed Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:YPSN:

FCF Margin %: -0.08%
GF Value™: CHF397.52 vs. price of CHF353.00 (11.2% below fair value)
GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ypsomed Holding AG Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies XSWX:TECN XSWX:SKAN XSWX:CLTN XSWX:VBSN XSWX:STMN ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST TSE:4543 XPAR:DIM XTER:SRT OCSE:COLO B NZSE:FPH SOLV ALGN

Other Exchanges YPSNz:UK 0QLQ:UK OWX:Germany

Address Brunnmattstrasse 6, Burgdorf, CHE, 3401

Website https://www.ypsomed.com

Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.

91GF Score

Get the complete analysis for XSWX:YPSN

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF353.00

Price

CHF397.52

GF Value

View XSWX:YPSN Analysis

See FCF Margin % data for all stocks →